Zhang et al. reported that phosphohistidine phosphatase 1 (PHPT1), often overexpressed and caused poor survival in lung cancer patients, could activate ERK/MAPK pathway targeting F-box protein 32 (FBXO32) as E3 ubiquitin ligase in EGFR mutant lung cancer (28). Here, EGFR is linked to lung cancer.